Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study).

Kitada M, Toyoda M, Sekine O, Suzuki D, Okada Y, Morita Y, Nishimura H, Satoh H, Kamiya H, Takamura T, Isono M, Onoue T, Arima H, Tanaka K, Miyamoto M, Omura Y, Yabe D, Kato T, Asano A, Wakasa Y, Miyamoto S, Kume S, Ito T, Araki SI, Nakagawa A, RESOLUTION Study Investigators

Open source

DOI: 10.1111/jdi.70173
Published: 2025 Dec
Container: Journal of diabetes investigation
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/jdi.70173,
  title = {Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study).},
  author = {Kitada M and Toyoda M and Sekine O and Suzuki D and Okada Y and Morita Y and Nishimura H and Satoh H and Kamiya H and Takamura T and Isono M and Onoue T and Arima H and Tanaka K and Miyamoto M and Omura Y and Yabe D and Kato T and Asano A and Wakasa Y and Miyamoto S and Kume S and Ito T and Araki SI and Nakagawa A and RESOLUTION Study Investigators},
  year = {2025},
  journal = {Journal of diabetes investigation},
  doi = {10.1111/jdi.70173},
  url = {https://doi.org/10.1111/jdi.70173}
}

RIS

TY  - JOUR
TI  - Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study).
AU  - Kitada M
AU  - Toyoda M
AU  - Sekine O
AU  - Suzuki D
AU  - Okada Y
AU  - Morita Y
AU  - Nishimura H
AU  - Satoh H
AU  - Kamiya H
AU  - Takamura T
AU  - Isono M
AU  - Onoue T
AU  - Arima H
AU  - Tanaka K
AU  - Miyamoto M
AU  - Omura Y
AU  - Yabe D
AU  - Kato T
AU  - Asano A
AU  - Wakasa Y
AU  - Miyamoto S
AU  - Kume S
AU  - Ito T
AU  - Araki SI
AU  - Nakagawa A
AU  - RESOLUTION Study Investigators
PY  - 2025
JO  - Journal of diabetes investigation
DO  - 10.1111/jdi.70173
UR  - https://doi.org/10.1111/jdi.70173
ER  -

APA

M, K., M, T., O, S., D, S., Y, O., Y, M., H, N., H, S., H, K., T, T., M, I., T, O., H, A., K, T., M, M., Y, O., D, Y., T, K., A, A., Y, W., S, M., S, K., T, I., SI, A., A, N., & Investigators, R. S. (2025). Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study).. Journal of diabetes investigation. https://doi.org/10.1111/jdi.70173

Source records

pubmed · retrieved 2026-09-26T21:54:38.999Z